These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 628401)

  • 1. Antibodies to oligodendroglia in multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1978 Mar; 298(13):743. PubMed ID: 628401
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to oligodendroglia in multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure D
    Trans Am Neurol Assoc; 1977; 102():15-8. PubMed ID: 616097
    [No Abstract]   [Full Text] [Related]  

  • 4. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunity to isolated human oligodendroglia in multiple sclerosis.
    Myers LW; Ellison GW; Fewster ME; Wolfgram F
    Trans Am Neurol Assoc; 1975; 100():107-9. PubMed ID: 1226591
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro study of the cytotoxicity of sera from patients with multiple sclerosis and other neurological diseases to cultured rat oligodendrocytes].
    Hirayama M; Kawai K; Iida M; Sobue I
    Rinsho Shinkeigaku; 1986 Aug; 26(8):835-40. PubMed ID: 3802676
    [No Abstract]   [Full Text] [Related]  

  • 7. Oligodendrocyte staining by multiple sclerosis serum is nonspecific.
    Traugott U; Snyder S; Raine CS
    Ann Neurol; 1979 Jul; 6(1):13-20. PubMed ID: 389147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
    Bartlett PF; Mackay IR
    J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescent staining of rat brain glial cells with multiple sclerosis serum.
    Singh VK; Mashal RD
    Can J Neurol Sci; 1981 May; 8(2):143-5. PubMed ID: 7028233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosis.
    Fewster ME; Ellison GW; Myers LW; Kirashige EY
    Neurology; 1975 Aug; 25(8):735-9. PubMed ID: 1080263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studies.
    Steck AJ; Link H
    Acta Neurol Scand; 1984 Aug; 70(2):81-9. PubMed ID: 6485748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A longitudinal study of immunological parameters in multiple sclerosis (author's transl)].
    Simon J; Mar P; Neu I; Kamm S; Schrader A
    Nervenarzt; 1980 Mar; 51(3):176-82. PubMed ID: 7453878
    [No Abstract]   [Full Text] [Related]  

  • 13. Oligodendrocyte-binding antibodies in multiple sclerosis: 125I-protein A studies.
    Steck AJ; Regli F
    Neurology; 1980 May; 30(5):540-2. PubMed ID: 7189260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F; Chojnacki A; Weiss S; Antel JP
    Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of antioligodendrocyte serum.
    Traugott U; Snyder S; Norton WT; Raine CS
    Ann Neurol; 1978 Nov; 4(5):431-9. PubMed ID: 367262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
    Schirmer L; Srivastava R; Hemmer B
    Mult Scler; 2014 Mar; 20(3):271-9. PubMed ID: 24589684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow microfluorometry detects IgM autoantibody to oligodendrocytes in multiple sclerosis.
    Pedersen JS; Walker M; Toh BH; De Aizpurua HJ; Lolait SJ; Bernard CC
    J Neuroimmunol; 1983 Dec; 5(3):251-9. PubMed ID: 6655048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls.
    Hirayama M; Lisak RP; Silberberg DH
    Neurology; 1986 Feb; 36(2):276-8. PubMed ID: 3945400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes.
    Ma BI; Joseph BS; Walsh MJ; Potvin AR; Tourtellotte WW
    Ann Neurol; 1981 Apr; 9(4):371-7. PubMed ID: 6452854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.